BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function  by Cantor, Sharon B. et al.
Cell, Vol. 105, 149–160, April 6, 2001, Copyright ª 2001 by Cell Press
BACH1, a Novel Helicase-like Protein, Interacts
Directly with BRCA1 and Contributes
to Its DNA Repair Function
to mediate double-strand break repair and homologous
recombination (Moynahan et al., 1999; Scully et al., 1999;
Zhong et al., 1999; Wu et al., 2000). They also possess
a transcription activation function (Chapman and Verma,
1996; Monteiro et al., 1996), which is abrogated by clini-
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cally relevant mutations. In keeping with the latter obser-and David M. Livingston*k
vations, the BRCT-containing region can interact with*The Dana-Farber Cancer Institute and the Harvard
the RNA polymerase holoenzyme (Scully et al., 1997a)Medical School
and with CtIP, a partner of the transcriptional corepres-Boston, Massachusetts 02115
sor, CtBP (Yu et al., 1998). However, the physiological†Center for Cancer Risk Analysis and
significance of these two interactions is unknown.‡Molecular Pathology Unit
In this regard, disease-associated mutations existMassachusetts General Hospital
throughout BRCA1, but the majority of them result in aCharlestown, Massachusetts 02129
truncated product with loss of the extreme C terminus§Microchemistry and Proteomics Analysis Facility
and one or both BRCT motifs (Breast Cancer InformationHarvard University
Core (BIC)). Clinically relevant missense mutations existCambridge, Massachusetts 02138
within each BRCT motif, implying a link between their
function and the execution of BRCA1-mediated tumor
suppression. These findings notwithstanding, there isSummary
little biochemical understanding of how BRCA1 func-
tions as a tumor suppressor. Nonetheless, the evidenceBRCA1 interacts in vivo with a novel protein, BACH1,
suggests that the genome integrity maintenance anda member of the DEAH helicase family. BACH1 binds
the tumor suppression functions are linked (Welcsh etdirectly to the BRCT repeats of BRCA1. A BACH1 deriv-
al., 2000).ative, bearing a mutation in a residue that was essen-
In an effort to understand how the BRCT sequencestial for catalytic function in other helicases, interfered
function, we have screened for proteins that contactwith normal double-strand break repair in a manner
them directly. The search has led to the identificationthat was dependent on its BRCA1 binding function. Thus,
of BACH1, a novel member of the DEAH helicase family.BACH1/BRCA1 complex formation contributes to a key
From the results of a cell biological analysis and a clinicalBRCA1 activity. In addition, germline BACH1 muta-
epidemiology study, it appears that BACH1 is a physio-tions affecting the helicase domain were detected in
logical partner of BRCA1, participating in the perfor-two early-onset breast cancer patients and not in 200
mance of both its DNA repair and its tumor suppressormatched controls. Thus, it is conceivable that, like
functions.BRCA1, BACH1 is a target of germline cancer-inducing
mutations.
Results
Introduction
Screen for BRCT Binding Proteins
A GST fusion protein containing residues 1529–1863,Germline mutations in BRCA1 lead to an increased life-
which spans both BRCT motifs and extends to thetime risk of breast and/or ovarian cancer. The gene en-
BRCA1 C terminus (GST-BRCT; Figure 1A), was gener-
codes an 1863 residue nuclear protein with an N-terminal
ated. The modified GST moiety was labeled by in vitro
RING and C-terminal BRCT domains. BRCA1 contains
phosphorylation with protein kinase A and used in far
little homology to known proteins. Evidence points to a Western blotting experiments (Blanar and Rutter, 1992;
role for this gene in the maintenance of genome integrity Kaelin et al., 1992) where it detected four bands ranging
and in certain transcription regulation events (Deng and from 50 to 220 kDa (whole-cell extract (WCE), Figure
Brodie, 2000). 1B). Among them was a protein of z130 kDa, which was
The C-terminal region of BRCA1 contains two BRCT also detected in 293T and U20S cell lysates (data not
(BRCA1 C-Terminal) motifs. These structures have been shown). This protein was also present in immunopre-
identified in many proteins engaged in genome integrity cipitates (IPs) generated with multiple BRCA1 mono-
control (Koonin et al., 1996; Bork et al., 1997; Callebaut clonal antibodies (mAbs) (for an example, see Figure
and Mornon, 1997) and, where studied, appear to partici- 1B, lane 3).
pate in specific interactions with selected target pro- Binding of the 130 kDa band to the GST-BRCT probe
teins. For example, XRCC1 heterodimerizes with DNA was compromised when clinically relevant point mutant
ligase III in a base excision repair complex, and the derivatives were used as the probe. One mutation
BRCT motifs of both proteins are engaged in this interac- [P1749R] led to greatly reduced binding and another
tion (Taylor et al., 1998). [M1775R] (see Figure 1A) completely abolished binding
For BRCA1, these motifs play a critical role in its ability of the 130 kDa protein (Figure 1C). Unlike their wild-type
(wt) counterpart, the GST-BRCT mutant proteins also
failed to interact with this polypeptide in solution (datakTo whom correspondence should be addressed (e-mail:
david_livingston@dfci.harvard.edu). not shown).
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Figure 1. The BRCT Repeats of BRCA1 Inter-
act with a Discrete Set of Polypeptides by
Far Western Analysis
(A) Map of BRCA1 showing the BRCT motif-
containing region (aa 1529–1863); this region
also served as a probe in far Western analy-
sis. Two different point mutations and the lo-
cation of the BRCA1 truncation present in the
HCC1937 cell line are noted with stars and
an arrow, respectively.
(B and C) Far Western assays of Hela whole-
cell lysates (WCE) and of immunoprecipitates
(BRCA1 preimmune rabbit and rabbit im-
mune, c23 polyclonal Ab). (B) A 130 kDa band
is present in a HeLa cell lysate and in an anti-
BRCA1 immunoprecipitate when wt BRCT
probe was used. (C) BRCT probes containing
the mutations, P1749R or M1775R, failed to
recognize the 130 kDa band.
Purification of the 130 kDa BRCA1 Binding Protein 17 (GenBank accession numbers AA397978, R16443,
AI218496). Based on this information, a full-length cDNATo purify the 130 kDa protein, a GST-BRCT fusion pro-
tein bound to glutathione sepharose beads (GSSH) was was generated, as described in Experimental Procedures.
The open reading frame of this clone predicts the syn-incubated with HeLa cell nuclear extract. After extensive
washing, proteins bound to the beads were eluted by thesis of a 1249 residue polypeptide (Figure 2B). When
this cDNA was transcribed and translated in vitro, itsboiling in SDS-containing buffer, electrophoresed on a
polyacrylamide SDS gel, and stained with Coomassie product comigrated with the endogenous 130 kDa pro-
tein and interacted with the wt GST-BRCT fusion protein,blue (data not shown). When sufficient quantities of nu-
clear extract were immunoprecipitated, the 130 kDa as described above (for an example, see Figure 4).
The N-terminal 888 residues of the protein revealband was readily detected by this approach. By con-
trast, it was not detected when either of the above noted strong homology to the catalytic and nucleotide binding
domains of known members of the DEAH helicase fam-BRCT mutant derivatives ([P1749R] or [M1775R]) was
substituted for the wt BRCT fusion protein. ily. Among others, this group includes the xeroderma
pigmentosum complementing group D (XPD) proteinThe 130 kDa band was excised from the gel and sub-
jected to tryptic digestion within the gel material. The (Weber et al., 1990; Vermeulen et al., 1997; Coin and
Egly, 1998) and human CHL1 (Amann et al., 1997; Figuredigest was eluted and subjected to microcapillary re-
verse phase HPLC and nanoelectrospray tandem mass 2C). The 130 kDa protein sequence contains the seven
helicase-specific motifs that are conserved amongspectrometry (MS/MS). The ensuing MS/MS spectra re-
vealed that the 130 kDa protein sequence contains pep- members of the DEAH family. This helicase domain is
48% homologous to the human CHL1 protein. Like thetide sequences (see Experimental Procedures) encoded
by three different EST sequences present on chromosome other members of this family, the helicase domain in-
Figure 2. The BACH1 Sequence Is Significantly Homologous to that of DEAH Helicases
(A) DEAH helicase homology blocks are shown in roman numerals. The putative nuclear localization sequence (black rectangle) is shown.
The helicase homology region of BACH1 spans residues 1–888. The BRCA1 binding domain spans residues 888–1063 (hatched box).
(B) The BACH1 amino acid sequence with its helicase homology region (1–888) (blue shaded region). The underlined, hatched area constitutes
the BRCA1 binding domain, and the solid underlined region is predicted to contain a nuclear localization sequence.
(C) Homology alignment of the helicase domains of Homo sapiens BACH1 (HsBACH1), CHL1 (HsCHL1), and XPD (HsXPD), and S. cerevisiae
Rad3 (ScRad3). Identical or similar amino acid residues are shaded. In addition, the seven conserved domains of known helicases are denoted
above the sequence, and the nucleotide and DNA binding domains are shown below the alignment. BACH1 contains a canonical DEAH
sequence in helicase box II. The (*) denotes the residues mutated in the cancer patients described in the text.
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cludes a nuclear localization signal (Figure 2A). How- ure 3A). The abundance of BACH1 in these cells was
reduced by comparison with that detected in MCF7 orever, unlike other DEAH family members, the 130 kDa
protein sequence contains a C-terminal extension of 293T cells (data not shown). Correspondingly, although
punctate BACH1 nuclear staining was detectable (Fig-unknown function (Figure 2A). This particular sequence
reveals 39% homology with synaptonemal complex pro- ure 3B, compare the lowermost middle panel with panel
2/lane 2), the intensity of the BACH1 nuclear dot patterntein 1, a major component of the transverse filaments
of developing meiotic chromosomes (Schmekel et al., was lower in HCC1937 cells than in other cell lines con-
taining intact BRCA1 (like MCF7) (Figure 3B). In keeping1996).
Given the identical sequence properties of the gel- with these observations, when we used higher concen-
trations of BACH1 mAb in HCC1937, BACH1 foci wereexcised 130 kDa protein and the cloned polypeptide,
their comigration in SDS gels, their ability to interact also readily detectable (data not shown).
When HCC1937 cells were reconstituted with full-specifically with the BRCT-containing region of BRCA1,
and the presence of a DEAH helicase domain, the 130 length BRCA1 by recombinant retroviral infection (Scully
et al., 1999), BRCA1/BACH1 complexes and costainingkDa protein was named BACH1 (for Brca1-Associated
C-terminal Helicase). The BACH1 gene was localized nuclear dots were again readily detected (Figures 3A
and 3B), even though the intracellular abundance ofto chromosome 17q22 between markers D17S791 and
D17S794, as defined by a Genemap 99 NCBI database BACH1 was unchanged (data not shown).
These findings complement the far Western blottingsearch.
From a multiple-tissue cDNA panel (Clonetech), BACH1 results showing that two intact BRCT repeat units of
BRCA1 are essential for a stable BRCA1/BACH1 interac-is ubiquitously expressed, with highest RNA levels in
testis (data not shown). This expression pattern is similar tion. They further imply that the intensity of the BACH1
nuclear dot pattern is dependent, at least in part, uponto that reported for BRCA1, which is present at some
level in all tissues but highest in testis (Miki et al., 1994; the ability of BACH1 to interact with BRCA1. Taken to-
gether, the data indicate that BACH1/BRCA1 complexZabludoff et al., 1996).
formation is accompanied by an enhancement of the
BACH1 immunostaining signal and the appearance ofBACH1 Is a Nuclear Protein that Interacts
a prominent BACH1 nuclear dot pattern. Moreover,with BRCA1 In Vivo
BARD1, absent from anti-BACH1 IPs of HCC1937 ly-Monoclonal antibodies to BACH1 were raised against
sates, reappeared in BACH1 IPs of BRCA1-reconstitu-recombinant GST-BACH1 (residues 647–1043) and
ted HCC1937 cells (Figure 3A). The coimmunoprecipita-against a BACH1 C-terminal peptide (NFKPSPSKNKGM
tion data and immunostaining results suggest thatFPGFK). Western blots of extracts from three different
BRCA1 and BACH1 interact in vivo. They also suggesthuman cell lines probed with these antibodies revealed
that the BARD1/BACH1 interaction is indirect, relyingthe presence of intact BACH1 in all extracts (data not
upon the independent association of each protein withshown). Furthermore, anti-BRCA1 or anti-BACH1 IPs
BRCA1.of extracts from asynchronously growing MCF7 cells,
independently performed with two BRCA1 and two
BRCA1 Binds to a Segment of the BACH1BACH1 mAbs, coprecipitated BRCA1 and BACH1 (Fig-
Carboxy-Terminal Regionure 3A). These data strongly suggest that BRCA1 and
To search for a region of BACH1 necessary for bindingBACH1 interact in vivo. The BRCA1 RING domain-asso-
BRCA1, a series of deletion mutants of BACH1 wereciated protein, BARD1, was also present in the IPs gen-
generated and S35-labeled products were synthesizederated with BACH1 mAbs and vice versa (Figure 3A),
by in vitro translation. These polypeptides were eachsuggesting that BACH1 exists in complex with both
incubated with the wt GST-BRCT (1529–1863) fusionBRCA1 and BARD1.
protein bound to GSSH beads, and binding of the rele-Immunofluorescence analysis using BACH1 mAbs re-
vant BACH1 species was examined after SDS gel elec-vealed the presence of punctate nuclear staining in
trophoresis and autoradiography (Figure 4). The datamultiple human cell lines. Focal BACH1 staining was
reveal that a discrete region of BACH1, C-terminal todetected in numerous, albeit not all, cells present in
the helicase domain and spanning residues 888–1063,asynchronous cultures. BRCA1 nuclear dots, as noted
is sufficient for BRCA1 binding (Figure 4).previously, were detected in S and G2 phase cells (Scully
et al., 1997c). In the majority of cells containing both
types of nuclear foci, many of these structures colo- Dominant Negative BACH1 Disrupts
Double-Strand Break Repaircalized with one another (Figure 3B). In synchronized
cell populations, nearly complete colocalization of BACH1 Having established that BACH1 associates with BRCA1
in vivo, we asked whether the interaction betweenand BRCA1 was detected in late S-G2 cells. Exposure
to gamma irradiation or hydroxyurea did not affect the BACH1 and the BRCT-containing region of BRCA1 con-
tributes to BRCA1 function. BRCA1 plays a major roleco-IP of BACH1 and BRCA1, and, like BRCA1, BACH1
underwent dynamic relocation to PCNA-containing in the repair of double-strand DNA breaks (Moynahan
et al., 1999; Scully et al., 1999; Snouwaert et al., 1999).structures after hydroxyurea exposure (data not shown)
(Scully et al., 1997b). Since BACH1 interacts with BRCA1 and belongs to the
DEAH helicase family, some members of which have aIn a line of BRCA12/2 cells (HCC1937) that synthesize
a mutant BRCA1 species with a truncated C-terminal role in DNA repair (Wood, 1999; Cleaver, 2000), we asked
whether BACH1 plays a role in double-strand break re-region affecting the integrity of the second BRCT motif
(Tomlinson et al., 1998) (see Figure 1A), this BRCA1 pair (DSBR). Specifically, we asked whether overexpres-
sion of a BACH1 mutant leads to a defect in DSBR. Aspecies and BACH1 failed to coimmunoprecipitate (Fig-
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Figure 3. The BACH1/BRCA1 Interaction Depends on an Intact BRCA1 C-Terminal Region
(A) Immunoprecipitation/Western blot analyses of lysates of MCF7, HCC1937, and HCC1937 reconstituted with wt BRCA1. Immunoprecipitates,
generated with the Abs denoted at the tops of the figures, were electrophoresed and blotted as described in Experimental Procedures. The
blots were probed with aBRCA1 (MS110; upper third segment), aBACH1 (2G7; middle third segment), or aBARD1 (c20; bottom third segment).
BACH1 was immunoprecipitated with either IB4 or IG5. BRCA1 was immunoprecipitated with either MS13 or SD118 . In the first experiment
(left panel), BARD1 immunoprecipitation was generated with c20 (aBARD1), and control precipitation was achieved with anti-myc monoclonal
antibody. The data presented in the other panels are from a second experiment.
(B) BACH1 and BRCA1 colocalize in nuclear dots in MCF7 cells, and colocalization in HCC1937 cells requires reconstitution with wt BRCA1.
Asynchronous MCF7 or HCC19372/2 BRCA1 cells were dually stained for BRCA1 (using affinity-purified, rabbit polyclonal antiserum to
BRCA1, red) and BACH1 (using monoclonal antibody to BACH1, green), as described in Experimental Procedures. Significant colocalization
of BRCA1 and BACH1 nuclear dots in a subpopulation of cells is reflected by the presence of yellow nuclear dots in the merged images.
BACH1 immunostaining was readily detected in the same HCC1937 cells (lowest middle panel) that were originally analyzed in lane 2/panel
2 when the intensity of exposure of the latter image was increased. BACH1 nuclear dots were also readily detected when the BACH1 antibody
concentration was increased 100-fold above that used in the other panels (data not shown).
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was detected following expression of the K52R mutant.
By contrast, it was not observed in the presence of
equivalent levels of either the wt or the double mutant
protein. These results indicate that K52R perturbs DSBR
in a dominant negative fashion. They further show that
this interfering effect is, in part, dependent on the ability
of BACH1 to bind BRCA1. Therefore, BACH1, like BRCA1,
appears to be important for DSBR, and the BACH1/
BRCA1 interaction contributes to the execution of this
BRCA1-dependent function.
Analysis of BACH1 Sequence Variants in Sporadic
and Familial Breast Cancer
Human genome analysis localized the BACH1 gene to
chromosome 17q22. This region is frequently targeted
by allelic losses in sporadic breast cancer, and failure
to detect BRCA1 mutations in these cases has sug-Figure 4. A Segment of the BACH1 C-Terminal Region Interacts
gested the presence of an additional tumor suppressorwith the BRCA1 BRCT Motifs
gene in this segment (Callahan, 1998). Given the evidenceVarious 35S-labeled, in vitro translated BACH1 polypeptides were
linking BACH1 to proper BRCA1-mediated DSBR andtested for binding to GST (2) or GST-BRCT:1529–1863 (1) fusion
protein. Input lanes display 50% of the input of each in vitro trans- prior evidence suggesting a relationship between BRCA1-
lated BACH1 protein. mediated DSBR and its tumor suppression function
(Scully et al., 1999), we initiated a search for mutations
in 21 cell lines derived from sporadic breast and ovarian
tumors. In addition, we screened the germline DNAs ofmissense mutation that converts a lysine to an arginine
was introduced at residue 52 (K52R). This residue is 65 individuals with early-onset breast cancer, of whom
35 had a strong family history of breast and/or ovarianconserved in numerous ATPases and helicases, and has
been shown to render the relevant protein incapable of cancer but lacked mutations in either BRCA1 or BRCA2
(Table 1). Mutational analysis involved direct nucleotidehydrolyzing ATP (Sung et al., 1988; Ma et al., 1994). A
double mutant, bearing both the K52R substitution and sequencing of RT-PCR amplified BACH1 cDNA. The
template for each cDNA was mRNA isolated from ana second mutation (DC 5 dl 888–1249) that eliminates
the BRCA1 binding domain of BACH1 (K52RDC), was immortalized B cell line generated with the relevant pa-
tient’s peripheral blood B cells. Mutation confirmationalso generated.
To assess DSBR in cells overproducing wt or mutant was performed by sequence analysis of the relevant,
individual exons, amplified from genomic DNA.BACH1, U2OS cells were transiently cotransfected with
a GFP-encoding vector and an expression vector en- Two heterozygous missense mutations were detected
in the germlines of two breast cancer patients. The firstcoding wt, K52R, or K52R/DC BACH1. Transfected cul-
tures were FACS sorted and the green fluorescing cells mutation, identified in a young woman with breast can-
cer who had a strong family history of breast and ovariananalyzed for expression of the relevant BACH1 species.
Standardized Western blot analysis demonstrated com- cancer, resulted in a proline to alanine substitution at
codon 47 (P47A). Unfortunately, germline DNA was notparable expression of the various proteins (Figure 5C).
The sorted cells were either mock treated or gamma available from any of this patient’s family members to
test for cosegregation of the mutation with breast cancerirradiated, and the abundance of double-strand breaks
(DSB) in each culture was analyzed. Previous experience in this kindred. However, the P47A mutation was not
detected in the germline DNAs of 200 control individuals,has shown that in multiple cell lines that synthesize wt
BRCA1, there is nearly complete resolution of DSB by indicating that it is unlikely to be a polymorphism in the
population (,1/400 alleles), although other polymor-six hours after irradiation (Scully et al., 1999 and data
not shown). Therefore, we analyzed DSB repair kinetics phisms were identified (see Table 1). The second germ-
line BACH1 mutation, M299I, was also detected in aat 0, 3, and 6 hr following exposure to irradiation by
pulsed field gel electrophoresis (Badie et al., 1995; Scully case of early-onset breast cancer and absent in 200
control individuals (Table 1). Both mutations resideet al., 1999). As shown in Figure 5A, after exposure to
15 Gy, U2OS cells overproducing the K52R mutant of within the region encompassing the helicase domain
of BACH1. Indeed, the P47A mutation resides withinBACH1 displayed a marked delay in repair, as shown
by an increase in the level of unrepaired breaks detect- a region resembling the highly conserved nucleotide
binding box of known DEAH helicases, while the M299Iable at 3 and 6 hr. Importantly, cells synthesizing the
double mutant, K52R/DC, which should neither hy- mutation is positioned between two other boxed motifs
(see Figure 2C). Given its location within a conserveddrolyze ATP nor bind BRCA1, revealed normal DSB re-
pair capacity at all time points (Figure 5A). With these box motif, we further investigated the P47A mutation.
Specifically, we incorporated this mutation into ankinetics in mind, we also performed a statistical analysis
of these effects, employing multiple experiments in otherwise wt BACH1 allele and expressed both mutant
and wt gene products in U2OS cells. Remarkably, de-which U20S DSBR was tested after transfecting the vec-
tor, alone, or vector encoding wt BACH1, K52R, or K52R/ spite comparable expression of the two transcripts (data
not shown), the abundance of the mutant gene productDC BACH1. Statistically significant perturbation of repair
BACH1, a BRCA1-Associated Protein
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Figure 5. The BACH1 K52R Mutant Interferes with the Timely Repair of Double-Strand Breaks
(A) U2OS cells were transfected with a GFP-encoding vector and either K52R or K52RDC, each expressed as a myc-6xhis-fusion protein. A
control culture was transfected with vector alone. GFP-positive cells were FACS sorted and either exposed or not exposed to 15 Gy and
harvested at the indicated times. Residual DSBs were determined by pulsed field electrophoresis as described in Experimental Procedures.
Composite data analyzing results at three time points from two individual DSBR experiments are shown for K52R, K52RDC, and vector. The
data are the averages of 2–3 measurements at each time point.
(B) To further assess effects at the 6 hr time point, multiple experiments were performed using BACH1 (wt), K52R, K52RDC, and vector alone,
as described above. These data represent the mean and standard error of several independent experiments with at least 2–3 measurements
per time point per experiment for each transfected culture.
(C) [Above], Maps of the primary structure of BACH1 (wt), K52R, and K52R/DC BACH1 are shown. [Below], FACS-sorted cells were lysed.
Lysates were immunoprecipitated with myc antibody, and the relevant Western blot was probed with myc antibody. Western blot analysis
showing that all three BACH1 proteins were expressed at the same level and were intact.
was considerably reduced, compared to the wt protein. imen prevented screening of the full BACH1 coding re-
gion for another mutation in the remaining allele or forTo determine whether this was attributable to altered
protein stability, the half-lives of the mutant and wt pro- any mutation that would restrict expression of the gene.
teins were determined. Using the cycloheximide/chase
method, the data indicated that BACH1 containing the Discussion
P47A substitution was considerably less stable (t1/2:
z1 hr) than either the wild-type protein (t1/2: z3 hr) or Endogenous BACH1, a new member of the DEAH family
of DNA helicases, interacts directly and specifically withthe K52R dominant negative mutant product (t1/2: z4 hr)
(Figure 6). These results suggest that the P47A alteration the BRCT motif-containing domain of BRCA1. More-
over, BACH1 likely contributes to the DNA repair func-constitutes a functionally significant mutation and sug-
gest that reduced protein levels attributable to this mu- tion of BRCA1, since a BACH1 derivative bearing a muta-
tion in a key residue that is essential for catalytic functiontant allele may be linked to breast cancer predisposition.
Analysis of a laser capture microdissected sample in other helicases interfered with normal DSBR in a man-
ner that was dependent upon its ability to interact withfrom this patient’s tumor did not reveal homozygosity
for the P47A change. However, prior fixation of the spec- BRCA1. Tumor-predisposing missense and deletion
Table 1. BACH1 Sequence Variations in Breast and Ovarian Cancer
Frequency
Familial
Breast and Early-Onset
Sequence Effect on Ovarian Breast Sporadic Sporadic
Variant Protein Cancer Cancer Breast Cancer Ovarian Cancer Controls
C139G PRO47ALA 1/35 0/30 0/13 0/8 0/200
G897A MET299ILE 0/35 1/30 0/13 0/8 0/200
Polymorphisms
G577A VAL193ILE 3/200
C2755T PRO919SER 11/21
G2637A None 12/21
C3411T None 10/23
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process include the localized unwinding of DNA in the
vicinity of a break. Enzymatic unwinding of DNA has
already been shown to be an essential element in certain
forms of DNA repair. For example, the XPD and XPB
helicases associated with transcription-repair factor
TFIIH are essential for nucleotide excision repair (re-
viewed in Coin and Egly, 1998), and this activity can
be modulated by other proteins (Drapkin et al., 1994;
Ohkuma and Roeder, 1994; Serizawa et al., 1994; Xiao
et al., 1994; Wang et al., 1995; Qadri et al., 1996). In this
context, the association of BRCA1 with a putative DNA
helicase may help to shed light on the role of BRCA1 in
the DSBR process.
Similarly, it will be interesting to determine whether
binding of BRCA1 affects the putative enzymatic func-
tion of BACH1. Alternatively, it is conceivable that
BACH1 operates upstream of BRCA1, influencing the
DSBR-promoting function of the latter, or reciprocal
BACH1 $ BRCA1 influence might exist after the creation
of a DS break. What remains especially unclear is how
and in what biochemical form the relevant influence is
transmitted. Direct communication between a C-termi-
nal segment of BACH1 and the BRCT motifs of BRCA1
would seem to be at least part of the story.
BRCA1 also functions in meiotic cells where it deco-
rates the unsynapsed segments of developing synapto-
nemal complexes. In these regions, sister chromatids
associate with one another in the presence of certain
axial element proteins, BRCA1, BRCA2, Rad51, ATR,
and other DNA replication/repair/checkpoint proteins
(Keegan et al., 1996; Scully et al., 1997b; Chen et al.,
1998; Yuan et al., 2000). Since the unsynapsed regions
will eventually participate in appropriate pairing of ho-
mologous chromosomes, one or more proteins that are
closely associated with them likely play(s) a role in
the pairing/recombination process. Interestingly, the
C-terminal region of BACH1 is homologous to SCP1Figure 6. The BACH1 P47A Tumor-Associated Mutant Is Unstable
(Schmekel et al., 1996), an important component of the
Stability of wt and various mutant species of BACH1 was assessed
axial element, raising the question of whether BRCA1/by cycloheximide-chase analysis. BACH1 wt, K52R, and P47A were
BACH1 complexes may play a role in meiotic recombi-each expressed as a myc-6xhis-fusion protein in U2OS cells (10 mg
nation.of each plasmid were transfected). Transfected cell lysates from
each time point were immunoblotted for the c-myc epitope with The requirement for integrity of the BRCA1 BRCT mo-
9E10 anti-myc Ab. The myc immunoblot was densitometrically tifs both for BACH1 binding and for BRCA1-mediated
scanned, and the intensity of each fusion protein band was plotted tumor suppression suggests a connection between these
to determine the relevant half-lives. This experiment was repeated two functions. An association between loss of function
three times with similar results.
of a helicase and either a decrease in cell viability or
disease production is well established. The DEAH heli-
case family play significant roles in basal transcription,
mutations in the BRCA1 BRCT domain, all of which ren- DNA repair, and chromosome transmission (reviewed in
der BRCA1 defective in its DSBR function, also dis- Hoeijmakers et al., 1996). In yeast, CHL1 appears to play
rupted BACH1 binding to BRCA1. These data imply that a role in chromosome transmission, significant compro-
BACH1 is integral to the role of BRCA1 in DSBR. mise of which can lead to nonviability. The Saccharo-
Several lines of evidence suggest a role for BRCA1 myces cerevisiae homolog of XPD, RAD3, is also es-
in DSBR. BRCA1 interacts with several proteins that are sential for cell viability (Prakash and Prakash, 1989;
intimately involved in this process, including Rad51 and Friedberg et al., 1995). In mammalian cells, XPD is part
the Mre11/Rad50/Nbs-1 (MRN) complex (Scully et al., of TFIIH, which is required for both basal transcription
1997b; Carney et al., 1998; Stewart et al., 1999; Zhong and nucleotide excision repair (Weber et al., 1990; Drap-
et al., 1999; Wang et al., 2000; Wu et al., 2000). Moreover, kin et al., 1994; Coin and Egly, 1998). Nonlethal muta-
BRCA1-deficient cells reveal a chromosome breakage tions of XPD are responsible for multiple genetic dis-
syndrome and defective DSBR (Shen et al., 1998; Moy- eases including xeroderma pigmentosum, Cockayne
nahan et al., 1999; Scully et al., 1999; Xu et al., 1999). Syndrome, and trichothiodystrophy (Coin and Egly,
These findings notwithstanding, the mechanism by 1998). These examples highlight the diverse, yet key,
which BRCA1 participates in the DSBR process remains roles played by members of the DEAH helicase family
in biological processes dependent upon the mainte-unclear. Events that are likely to be intrinsic to the repair
BACH1, a BRCA1-Associated Protein
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ing step, the supernatants were further incubated with z60 ml ofnance of proper DNA mechanics. They also underscore
packed glutathione agarose beads loaded with approximately 20the close links that exist between abnormal/inadequate
mg of GST-BRCT fusion protein for 2 hr at 48C. The beads wereDNA mechanics and the emergence of disease.
then collected by centrifugation and washed four times in NET-N
In this context, it was interesting to detect an associa- containing 300 mM NaCl. Finally, the beads were boiled in SDS
tion between germline BACH1 mutation and breast can- loading buffer containing 10% b-mercaptoethanol and analyzed by
SDS-PAGE (10% gels). The gels were either stained or transferredcer development. In particular, two independent germ-
to nitrocellulose (Schleicher & Schuell) and subjected to far Westernline BACH1 mutations were found among a cohort of
blotting analysis. Where indicated, the 130 kDa BACH1 band was65 women with early-onset breast cancer, including one
visualized with Coomassie blue, excised from the gel, and subjectedwith a strong family history of breast and/or ovarian
to sequence analysis.
cancer but normal BRCA1 and BRCA2 genotypes. The
mutation at proline 47, a highly conserved residue within Mass Spectrometry
the nucleotide binding domain of the DEAH family, is The excised BACH1 gel bands were subjected to reduction, carboxy-
associated with BACH1 protein destabilization. Thus, amidomethylation, and tryptic digestion (Promega) within the rele-
vant gel strips. Multiple peptide sequences were determined in athe P47A sequence change is most likely a loss-of-func-
single run by microcapillary reverse phase chromatography directlytion mutation. While there is clearly no evidence indicat-
coupled to an LCQ quadruple ion trap mass spectrometer (Finnigan),ing that mutation at BACH1 is a common source of
equipped with a custom nanoelectrospray source. The column was
inherited breast cancer, the fact that BACH1 mutations packed in-house with 5 cm of C18 support into a one-piece 75 mm
exist in certain early-onset breast cancer patients and ID column terminating in a 15 mm tip (New Objective). Flow rate
not in 200 normal controls heightens speculation that, was 190 nl/min. The ion trap was programmed to acquire three
successive scan modes consisting of: full scan MS over alternatinglike the case of DSBR, BACH1 activity is linked to BRCA1
ranges of 395–800 m/z and 800–1300 m/z, followed by two data-tumor-suppressing function. Of note, loss of heterozy-
dependent scans on the most abundant ion in those full scans.gosity (LOH) was not observed in cells from the tumor
These dependent scans allowed the automatic acquisition of a high
of the patient with a BACH1 P47A germline mutation. resolution (zoom) scan to determine charge state, exact mass, and
However, inherent limitations in the method of analysis MS/MS spectra for peptide sequence information at ,10 fmol. MS/
make it unclear whether or not the other BACH1 allele MS spectra were acquired with a relative collision energy of 30%,
an isolation width of 2.5 Da, and recurring ions were dynamicallyis intact. If BACH1 is intact, this would raise the question
excluded. Interpretation of the resulting MS/MS spectra was facili-of whether heterozygosity at BACH1 translates into
tated by programs developed in the Harvard Microchemistry Facilityhaploinsufficiency. In such a case, somatic mutations in
(Chittum et al., 1998) and by database correlation with the algorithm
other genes might follow, with the subsequent mutation SEQUEST (Eng et al., 1994). The following peptides were identified:
collection contributing to the emergence of a neoplastic TNFDELLQVYYDAIK, VSIGLDFSDDNAR, AVITIGIPFPNVK, WLSTGL
phenotype in the relevant tumor cells. WHNLELVK, TVIVEPQGGEK, IDATLTR, TTWINELELGK, DLFEIR, ALN
QALGR, QWYEIQAYR.The potential existence of a clinical association be-
tween a germline mutation in BACH1 and early-onset
Immunoprecipitation, Immunoblotting, and Stability Analysisbreast cancer is intriguing and leads to speculation of
Cultured cells were washed once with 10 mM sodium phosphatea more general role for BACH1 in cancer suppression.
buffer (pH 7.4) containing 150 mM NaCl (PBS) and lysed in NET-N
Unquestionably, broader epidemiological and formal buffer. In a typical immunoprecipitation reaction, 100–300 mg of
human genetic analyses, as well as targeted mutation whole-cell extract was incubated with 1 mg of antibody and 20 ml
of the Bach1 gene in the mouse, will be needed to ad- of protein A Sepharose beads (1:1) at 48C for 1–2 hr. Beads were
washed four times in 1 ml of NET-N buffer. Proteins bound to thedress this possibility.
beads were eluted by boiling in SDS sample buffer, separated by
SDS-PAGE, and transferred to nitrocellulose membranes (Schlei-Experimental Procedures
cher & Schuell) using a semidry blotter (milliBlot-SDE system; Milli-
pore). The membranes were used for far Western blotting (KealinGlutathione S-transferase (GST) Fusion Proteins
et al., 1992) or for immunoblotting as described (Chen et al., 1998).GST and GST fusion proteins were expressed in E. coli BLR (Nova-
Cycloheximide-chase experiments on transfected cells were per-gen) transformed with pGEX2TK, pGST-BRCT, pGST-BRCT1749, or
formed as described (Maki and Howley, 1997).pGST-BRCT1775. Fusion proteins were purified by affinity chroma-
tography using glutathione Sepharose beads (Pierce) as described
(Kaelin et al., 1992). The relative protein concentration was estimated Plasmids
by Coomassie blue staining. Purified GST proteins were used in affin- Full-length BACH1 cDNA was constructed from two phage con-
ity/protein binding experiments (Chen et al., 1998) using either HeLa taining partial cDNA fragments and a 59 RACE product generated
cell nuclear extracts or in vitro translated 35S-labeled proteins. The as described by the manufacturer of the relevant kit (Gibco BRL).
latter were generated with the TNT system (Promega). Beads were The fragments were digested and ligated together to produce a full-
extensively washed in NET-N buffer [150 mM NaCl, 0.5% NP-40, 20 length BACH1 sequence in a pBluescript II KS1/2 vector (Stratagene).
mM Tris-HCl (pH8), 1 mM EDTA]. Bound proteins were separated It was sequenced fully and found to be intact before use in experi-
by SDS-PAGE (10% gels) and/or visualized by autoradiography. For ments described here. To generate a mammalian expression plas-
far Western blotting experiments, the pGEX2TK fusion proteins were mid encoding myc1 his-tagged full-length BACH1, the pBluescript
labeled with 32P-ATP as described (Amersham Pharmacia Biotech) vector containing wt BACH1 cDNA was digested with Not1 and
and used as radioactive probes (Kaelin et al., 1992). Apa1 to release the full-length BACH1 sequence. The excised, full-
length BACH1 sequence was subcloned into the pCDNA3myc-6xhis
vector (Invitrogen) to generate an in-frame polypeptide fused withBACH1 Purification and Sequencing
Ten liters of HeLa cells, purchased from Cell Culture Science (Minne- the C-terminal myc-6xhis tag.
Sequences encoding truncated derivatives of BACH1 were gener-apolis, MN), were resuspended in low salt NET-N buffer. After a
slow speed spin (1100 RPM), the pellet was lysed in 300 mM NaCl- ated by PCR using the wt BACH1 pBluescript vector as a template
and the following primers: for the helicase domain derivative, [TTGcontaining NET-N buffer for 20 min on ice and then centrifuged at
15,000 RPM for 20 min. These supernatants were incubated with CGGCCGCGCCACCATGGCACTTCATCAACTTGTCAAGATT] and [TTG
GGCCCGGAAAATTCAGCCAAGGACTCCAG]; for the C-terminal do-z60 ml of packed glutathione agarose beads loaded with approxi-
mately 1 mg/ml of GST protein for 2 hr at 48C. Following this preclear- main-containing derivative, [TTGCGGCCGCGCCACCATGGATCCA
Cell
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AAAAAGAAGAGAAAGGTATCCTTGGCTGAATTTTCCAAAAAG] and Double-Strand Break Repair Assay
Cells were cotransfected with BACH1 species and GFP, sorted after[AAGGGCCCCTTAAAACCAGGAAACATGCCTTTATTTTTGG]; and for
the BRCA1 binding domain-containing derivative, [TTGCGGCCGCG 24 hr by virtue of their GFP-associated fluorescence, and plated at
400,000 cells per 60 cm dish. 40 hr after transfection, the cellsCCACCATGGATCCAAAAAAGAAGAGAAAGGTATCCTTGGCTGAA
TTTTCCAAAAAG] and [AAGGGCCCTGTGTTTACTGTCAGATTTGA were either irradiated or mock irradiated and allowed to recover for
various time points and then analyzed for their ability to performGGATTC].
These products were subcloned into a pCDNA3myc-6xhis vector DSBR, as described (Scully et al., 1999). Cells were irradiated with
a 137 Cs source at 48C and allowed to repair DNA breaks at 378C.(Invitrogen) in frame with the C-terminal myc-6xhis tag. To insure
that the BACH1 C-terminal and BRCA1 binding domain fusion pro- At the indicated times, cellular DNA was analyzed by pulse field gel
electrophoresis as described (Badie et al., 1995). After electrophore-teins localized to nuclei, an SV40 nuclear localization sequence was
included in the 59 primer. sis, the gel was processed and stained with SYBR green as de-
scribed (Kiltie and Ryan, 1997). Fluorescence was quantitated withTo inactivate the putative ATPase activity of BACH1, the lysine
residue at position 52 was changed to an arginine, using a Quik- a Molecular Dynamics Storm Scanner using the blue fluorescence
channel and ImageQuant software (Molecular Dynamics). The frac-change site-directed mutagenesis kit (Stratagene). Two primers
were used in this process: [CCCACAGGAAGTGGAAGGAGCTT tion of DNA entering the gel was measured using the formula: Per-
cent release 5 (signal in lane)/[(signal in lane) 1 (signal in plug)]/AGCCTTAGCC] and [GGCTAAGGCTAAGCTCCTTCCACTTCCTGT
GGG]. To generate the (K52RDC) mutation, the helicase primers, 100. The quantity of signal present in unirradiated, parallel control
cultures (,10% of total input DNA in a given lane) was taken as alisted above, were used with the (K52R) mutant BACH1 template.
All newly generated recombinants were sequenced. To generate the measure of background signal and subtracted from the measured
values. For kinetic studies, the data presented were normalized totumor-associated mutant, the proline at position 47 was changed to
an alanine by Quikchange site-directed mutagenesis (Stratagene) the percent DNA released into the gel at T 5 0.
using the following primers: [CATTGTTTGTTGGAGAGTGCCACA
GGAAGTGGAAAAGC] and [GCTTTTTCCACTTCCTGTGGCACTCTC Clinical Study Population
CAACAAACAATG] EBV-immortalized lymphoblastoid cell lines from 65 women diag-
The BRCT-GST fusion protein was generated by PCR using the nosed with breast cancer before the age of 40 were analyzed for
following primers: [ATCGGATCCATTAAGGTTGTTGATGTGGAG] BACH1 germline mutations. Sixteen cases had a definitive (3 or
and [AAGGATCCTCAGTAGTGCTGTGGGGGATCTG]. The product more affected individuals over 2 or more generations) family history
was digested with BamH1/Sal1 and subcloned into pGEX2TK. The of breast cancer, and 19 other individuals had a positive family
generation of M1775R and P1749R derivatives was carried out by history of breast-ovarian cancer. The remaining cases of early-onset
standard PCR cloning techniques. Each derivative was verified by breast cancer represent a subset of the general population at high
standard sequencing techniques. Templates containing these muta- risk for genetic predisposition. These individuals were part of a
tions were used with above-noted primers to introduce the larger cohort of 408 women with early-onset breast cancer from
BRCT1775 and BRCT1749 mutations into the pGEX2TK vector. Boston area hospitals (FitzGerald et al., 1996). Control EBV-immor-
talized lymphoblastoid cell lines were established from healthy
In Vitro Protein Binding Reactions blood donors registered in the blood banks of these hospitals. Both
Expression plasmids encoding the full-length BACH1 and BACH1 the early-onset breast cancer study group and the control popula-
polypeptides, generated as described above, were in vitro translated tion represent individuals within the Boston area. The two groups
(TNT kit, Promega) and tested for binding to GST (2) or GST- are well matched with respect to ethnicity as confirmed by equal
BRCT:1529–1863 (1) fusion protein. contribution in the two populations of multiple polymorphic se-
quences. Thirteen sporadic breast cancer cell lines and 8 ovarian
cancer cell lines were obtained from the American Type CultureCell Culture
U20S and 293T cells were cultivated in Dulbecco’s modified Eagle’s Collection (Manassas, VA). They are: MDA-MB-415, MDA-MB-436,
MDA-MB-453, MDA-MB-231, MDA-MB-157, MDA-MB-468, MDA-medium (DMEM) containing 10% fetal calf serum (HyClone) at 378C
in a 10% CO2-containing atmosphere. MCF7 cells were maintained MB-435, MDA-MB-175, HS157, MCF7-ADR, HS275, T47D, BT549,
OVCAR-3, OVCAR-4, OVCAR-5, OVCAR-8, OV1063, IGROV-1,in DMEM supplemented with 10% fetal bovine serum (HyClone). For
transfection, a standard calcium phosphate precipitation method was MDA-2774.
used (Chen and Okayama, 1987). Cells were collected 48 hr after
transfection. Mutation Detection
Denaturing HPLC was used to detect mutations within the BACH1
Immunostaining coding region. Total mRNA was isolated using STAT-60 (Tel-test,
MCF7 cells were grown on coverslips, fixed with 3% paraformalde- Inc., Friendswood, TX). The entire BACH1 transcript was amplified
hyde/2% sucrose in PBS for 10 min., and permeabilized with 0.5% in an RT-PCR reaction with primers BACH1-PRIM-F (GAATCGGAG
Triton X-100 as described previously (Scully et al., 1997c). Cells CTCAGAGCGTTGCTTCG) and BACH1-PRIM-R (GGGCAACAGAC
were then incubated with mouse monoclonal antibodies to BACH1 CAAGACTCTGTCTC) for 25 cycles at 958C for 30 s, 588C for 30 s,
(2G7 or 1G5 at 1:50–1:100) and polyclonal anti-sera to BRCA1 (at and 728C for 4 min. Products of this reaction were diluted 100-fold
1:500) in PBS with 1% bovine serum albumin. After washing, appro- and used as templates in subsequent nested PCR analyses to gener-
priate species-specific, fluorochrome-conjugated secondary anti- ate 14 overlapping fragments for dHPLC analysis. Primers and PCR
bodies (Jackson ImmunoResearch Laboratories) were applied as conditions are available upon request. Wavemaker software (Trans-
recommended by the manufacturer, and fluorescence was visual- genomic, Ohmaha, NE) and the Stanford prediction program (avail-
ized using a Nikon microscope. able at http://insertion.stanford.edu/melt.html) were used to predict
the optimal temperatures for mutational analysis of each amplicon.
Aberrant dHPLC profiles were confirmed by sequencing after ream-Antibodies
Some of the anti-BRCA1 mAbs used were described previously plification of the fragment with primers that included M13-tailed
primers. For sequencing analysis, PCR products were resolved by(Scully et al., 1996; Chen et al., 1998). BARD1 antibody was made
by subcloning a BglII-XhoI fragment of BARD1 cDNA, encoding gel electrophoresis, treated with exonuclease I (Amersham Life Sci-
ences) and with shrimp alkaline phosphatase (United States Bio-residues 201–777, into the BamHI-XhoI sites of pGEX-4T-1 to gener-
ate the vector for the expression of GST-BARD1 fusion protein. GST chemical). They were then diluted 6-fold prior to sequencing. Energy
Transfer Dye Primer (Amersham Pharmacia Biotech) sequencingfusion protein purification, antibody production, and purification
were performed as described previously (Scully et al., 1996; Chen was performed according to the manufacturer’s instructions. Poten-
tially heterozygous nucleotides were marked and displayed for eval-et al., 1998). Two mouse monoclonal antibodies, generated against
a specific BACH1 peptide (NFKPSPSKNKGMFPGFK) (PP15-IB4 and uation by Factura and Sequence Navigator (Applied Biosystems).
Specifically, base positions at which the height of the secondaryPP112G7), and a third raised against GST-BACH1 (647–1043) (GO-
IG5) were also used where indicated. peak was .30% that of the primary peak were marked as heterozy-
BACH1, a BRCA1-Associated Protein
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gous and were confirmed by analysis of both sense and antisense beyond its UGA stop codon by multiple suppressions and transla-
tional reading gaps. Biochemistry 37, 10866–10870.strands. For LOH analysis, as reflected by the nature of the sequence
at the codon responsible for residue 47, paraffin-embedded tumor Cleaver, J.E. (2000). Common pathways for ultraviolet skin carcino-
blocks were sectioned and subjected to laser capture microdissec- genesis in the repair and replication defective groups of xeroderma
tion to isolate homogeneous regions of histologically normal cells pigmentosum. J. Dermatol. Sci. 23, 1–11.
and tumor cells. DNA was extracted using phenol-chloroform fol-
Coin, F., and Egly, J.M. (1998). Ten years of TFIIH. Cold Spring Harb.
lowed by ethanol precipitation. A genomic DNA fragment spanning
Symp. Quant. Biol. 63, 105–110.
codon 47 was amplified using forward (GATTAAACAGCAAGCAA
Deng, C.X., and Brodie, S.G. (2000). Roles of BRCA1 and its inter-CATTGTTTG) and reverse (CATGCTAAAGCAGAACAAAGTAAGG)
acting proteins. Bioessays 22, 728–737.primers. PCR conditions consisted of: 35 cycles of 958C for 30 s,
Drapkin, R., Reardon, J.T., Ansari, A., Huang, J.C., Zawel, L., Ahn,588C for 30 s, 728C for 30s.
K., Sancar, A., and Reinberg, D. (1994). Dual role of TFIIH in DNA
excision repair and in transcription by RNA polymerase II. NatureAcknowledgments
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